SEC Form 4 · accession 0001179110-15-001100
KYTHERA BIOPHARMACEUTICALS INC · KYTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Camille D Samuels
Director
Period of report
Jan 16, 2015
Accepted (ET)
Jan 21, 2015 · 8:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001436304
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 16, 2015 | S | 100 | $36.22 | D | 15,835 | D | |
| Common StockF2 | Jan 16, 2015 | S | 150 | $37.02 | D | 15,685 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to the Reporting Person's 10b5-1 plan which expires December 31, 2015.
- F2Reflects the pro rata distribution of an aggregate of 15,935 shares from Versant Ventures II, LLC to the Reporting Person as follows: 4,519 shares on October 3, 2013, 4,965 shares on October 15, 2013, and 6,451 shares on March 4, 2014. The Reporting Person no longer has beneficial ownership of shares previously reported as indirectly held by Versant Venture Capital II, L.P., Versant Side Fund II, L.P., Versant Affiliates Fund II-A, L.P. and Versant Venture Management LLC.